Guangdong Biolight Meditech Co., Ltd. (SHE:300246)

China flag China · Delayed Price · Currency is CNY
14.43
-0.21 (-1.43%)
Jan 23, 2026, 3:04 PM CST
130.88%
Market Cap3.78B
Revenue (ttm)1.05B
Net Income (ttm)-66.14M
Shares Out261.61M
EPS (ttm)-0.25
PE Ration/a
Forward PEn/a
Dividend0.10 (0.69%)
Ex-Dividend DateNov 26, 2025
Volume25,225,965
Average Volume23,525,116
Open14.03
Previous Close14.64
Day's Range14.03 - 14.85
52-Week Range5.43 - 14.98
Beta0.43
RSI76.80
Earnings DateApr 25, 2026

About SHE:300246

Guangdong Biolight Meditech Co., Ltd. engages in the research and development, production, sale, and service of medical devices products and solutions in China. It operates in two segments, Life Information and Support, and Kidney Disease. The company offers emergency and critical care monitor, subcritical care monitor, general ward monitor, outpatient monitor, neonatal monitor, infusion pump, electrocardiograph, maternal and fetal monitor, defibrillator, multifunctional suspension device, internet of things, and central station; hemodiafiltrat... [Read more]

Sector Healthcare
Founded 1993
Employees 1,335
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300246
Full Company Profile

Financial Performance

In 2024, SHE:300246's revenue was 1.06 billion, a decrease of -11.18% compared to the previous year's 1.19 billion. Losses were -71.44 million, 9.60% more than in 2023.

Financial Statements